Back to ROSG Stock Lookup

Rosetta Genomics (ROSG) – Press Releases

Mar 23, 2016 04:05 PM Rosetta Genomics Reports 2015 Full Year Financial Results
Mar 17, 2016 08:30 AM Rosetta Genomics to Host Business Update and 2015 Year-End Financial Results Conference Call on March 23, 2016
Feb 29, 2016 09:00 AM Rosetta Genomics Appoints Ana C. Ward as Executive Vice President, Legal and Corporate Development
Feb 25, 2016 09:00 AM Rosetta Genomics Expands Molecular Diagnostics Test Menu with Launch of Three New Product Offerings
Feb 18, 2016 09:00 AM Rosetta Genomics Receives Approval from New York State for First-of-its-kind Thyroid Cancer Diagnostic Assay
Feb 8, 2016 08:00 AM Rosetta Genomics to Present at Source Capital's 2016 Disruptive Growth & Healthcare Conference
Feb 1, 2016 08:00 AM Rosetta Genomics Announces Agreement with America’s Choice Provider Network for Entire Suite of Diagnostic Tests and Services
Jan 25, 2016 08:00 AM Rosetta Genomics Granted U.S. Patent Allowance for Use of Gene Expression Signature for Classification of Kidney Tumors
Jan 11, 2016 09:11 AM Rosetta Genomics Granted U.S. Patent Allowance for Use of microRNA Molecules for the Treatment of Liver Cancer
Jan 6, 2016 08:00 AM Rosetta Genomics Grants Sublicenses to Mirna Therapeutics for microRNA-related Patents for the Development of Oncology Therapeutics
Dec 14, 2015 08:00 AM Rosetta Genomics and Biocept Advance Collaboration to Proof-of-Concept Studies Aimed at microRNA Profiling of Circulating Tumor Cells to Enhance Lung Cancer Diagnosis
Dec 1, 2015 08:00 AM Rosetta Genomics Reports Third Quarter 2015 Financial Results
Nov 12, 2015 08:58 AM Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal™ (Thyroid microRNA Classifier)
Nov 4, 2015 08:30 AM Rosetta Genomics Appoints Dr. Maria Fe Paz as Interim Chief Medical Officer
Oct 26, 2015 05:19 PM Rosetta Genomics Reports Financial Results for the First Half of 2015
Oct 21, 2015 09:20 AM Positive Performance Data from Validation Study of Rosetta Genomics’ microRNA-based Diagnostic Assay for Thyroid Nodule Classification Presented at the International Thyroid Congress and Annual Meet
Oct 20, 2015 08:30 AM Rosetta Genomics to Host Business Update and Six Month Financials Conference Call on October 27, 2015
Oct 14, 2015 07:00 AM Rosetta Genomics Raises $8,000,000 in Private Placement
Oct 12, 2015 08:30 AM Rosetta Genomics Launches BRAF Mutation Assay
Oct 1, 2015 08:30 AM Rosetta Genomics to Present at 2015 Aegis Growth Conference
Sep 30, 2015 09:15 AM Rosetta Genomics to Partner with FNApath to Provide Centralized Laboratory Testing Services for Thyroid Cancer
Sep 22, 2015 08:57 AM Rosetta Genomics Receives U.S. Patent for Treatment of Prostate Cancer
Sep 4, 2015 10:34 AM CORRECTING and REPLACING Rosetta Genomics to Present at the 17th Annual Rodman & Renshaw Global Investment Conference
Sep 4, 2015 10:34 AM Rosetta Genomics to Present at the 17th Annual Rodman & Renshaw Global Investment Conference
Aug 6, 2015 09:00 AM Rosetta Genomics Receives Conditional Approval from New York State for Lung Biomarker
Aug 6, 2015 08:00 AM Rosetta Genomics Receives Accreditation from College of American Pathologists for its Laboratory in California
Jul 28, 2015 08:00 AM Rosetta Genomics Expands High-Value Molecular Diagnostic Offering with Launch of OncoGxSelect™
Jul 9, 2015 10:00 AM Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
Jul 8, 2015 05:38 PM Rosetta Genomics Files Pro Forma Financials in Connection with PersonalizeDx Acquisition
Jul 1, 2015 08:00 AM Rosetta Genomics Announces Participation in Cantor Fitzgerald’s Inaugural “From Bench to Bedside” Healthcare Conference
Jun 16, 2015 08:30 AM Rosetta Genomics Announces Agreement with MultiPlan for its PersonalizeDx Suite of Testing Services
May 28, 2015 09:06 AM Rosetta Genomics Launches OncoGxOne™
May 26, 2015 09:00 AM Rosetta Genomics Announces Selection of First Pilot Project Grant under Strategic Alliance with Moffitt Cancer Center
May 14, 2015 08:48 AM Rosetta Genomics Launches Two Assays for Bladder Cancer
May 13, 2015 09:07 AM Rosetta Genomics Receives Additional U.S. Patent Protection for the Cancer Origin Test™
May 12, 2015 08:23 AM Data on Rosetta Genomics’ Novel Thyroid Nodule Classification Assay to be Presented at the American Association of Clinical Endocrinologists 24th Annual Scientific and Clinical Congress
Apr 29, 2015 08:56 AM Rosetta Genomics’ Patent on Therapeutic Use of miR-34a Upheld by European Patent Office in Opposition Proceedings
Apr 20, 2015 08:30 AM Rosetta Genomics Announces Data Published in Leukemia Research
Apr 16, 2015 09:15 AM Rosetta Genomics Receives Key U.S. Patent Allowance for its Cancer of Origin Diagnostic Assay
Apr 14, 2015 08:30 AM Rosetta Genomics Completes Acquisition of PersonalizeDx
Apr 9, 2015 12:16 PM Rosetta Genomics to Acquire PersonalizeDx
Mar 26, 2015 08:30 AM Rosetta Genomics Receives Key U.S. Patent Allowance for its Novel Kidney Cancer Test
Mar 25, 2015 08:00 AM Rosetta Genomics to Launch Next-Generation Sequencing Panel from Admera Health
Mar 16, 2015 04:30 PM Rosetta Genomics Reports 2014 Financial Results
Mar 10, 2015 12:31 PM Rosetta Genomics to Host Business Update and 2014 Year End Financials Conference Call on March 17, 2015

Back to ROSG Stock Lookup